Cornhulio, following link on current proceedings.
December 7, 2016 - UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) / The trial will be supported by Transgene and Bristol-Myers Squibb http://www.transgene.fr/wp-content/...7-Collaboration_UC_Davis_Transgene-BMS_EN.pdf
- Forums
- ASX - By Stock
- VHL - Transgene TG4011 & TG4010
Cornhulio, following link on current proceedings. December 7,...
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $22.35K | 558.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 221774 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 860576 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249700 | 0.043 |
3 | 145000 | 0.042 |
6 | 477461 | 0.041 |
7 | 247800 | 0.040 |
3 | 130000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 99540 | 2 |
0.047 | 18686 | 2 |
0.048 | 200000 | 1 |
0.049 | 194091 | 3 |
0.050 | 427445 | 9 |
Last trade - 14.51pm 19/11/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |